Back to top
more

McKesson (MCK)

(Delayed Data from NYSE)

$550.72 USD

550.72
463,800

+3.25 (0.59%)

Updated Aug 27, 2024 04:00 PM ET

After-Market: $551.01 +0.29 (0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 32% (170 out of 251)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Nevro's (NVRO) FDA Submission to Treat Patients With PDN

by Zacks Equity Research

Nevro's (NVRO) submission of a pre-market approval supplement to the FDA to seek approval for its Senza System can help in the treatment of chronic pain associated with PDN.

Why You Must Add Merit Medical (MMSI) Stock to Your Portfolio

by Zacks Equity Research

Investor optimism is high on Merit Medical (MMSI) stock, courtesy of solid prospects.

HMS Holdings (HMSY) to be Acquired by Gainwell for $3.4B

by Zacks Equity Research

HMS Holdings (HMSY) entered into an agreement to be acquired by Gainwell in an all-cash transaction deal worth about $3.4 billion.

Here's Why You Should Retain Cooper Companies (COO) Stock

by Zacks Equity Research

Cooper Companies (COO) continues to benefit from solid CVI and CSI product portfolios.

Intersect ENT (XENT) Banks on SINUVA Sales Amid COVID-19 Woes

by Zacks Equity Research

Intersect ENT's (XENT) potential in chronic sinusitis market and progress in SINUVA and PROPEL product lines are encouraging.

Urmimala Biswas headshot

5 Finest GARP Stocks Based on Discounted PEG

by Urmimala Biswas

Here we discuss five GARP stocks, TAP, OMI, TD, MCK and HMC, which while trading cheap at this moment, are generating robust growth rates on strong fundamentals.

Masimo's (MASI) Telehealth Solution Helps in COVID-19 Crisis

by Zacks Equity Research

Masimo (MASI) is lending support to Renown Health through Masimo SafetyNet in order to manage the COVID-19 surge.

Here's Why You Should Retain Allscripts (MDRX) Stock for Now

by Zacks Equity Research

Investor confidence is high on Allscripts (MDRX) stock on the back of its solid prospects.

    Here's Why You Should Retain AmerisourceBergen (ABC) Now

    by Zacks Equity Research

    AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment and new product launches.

    Abiomed's (ABMD) ECMO Technology Completes Successful Treatment

    by Zacks Equity Research

    Abiomed (ABMD) successfully treats first two patients in the world with the help of its Breethe OXY-1 System.

    Here's Why You Should Retain Stryker Stock Right Now

    by Zacks Equity Research

    Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako and broad product portfolio. However, pricing pressure raises concern.

    NextGen (NXGN) Solutions Support COVID-19 Vaccine Distribution

    by Zacks Equity Research

    NextGen (NXGN) lends a hand to the nationwide rollout of COVID-19 vaccines through its robust EHR platform and integrated solutions.

    Should Value Investors Buy McKesson (MCK) Stock?

    by Zacks Equity Research

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

    MCK vs. WST: Which Stock Is the Better Value Option?

    by Zacks Equity Research

    MCK vs. WST: Which Stock Is the Better Value Option?

    Here's Why You Should Hold on to McKesson (MCK) Stock Now

    by Zacks Equity Research

    McKesson (MCK) continues to benefit from multi-year strategic growth initiative and Distribution Solutions segment.

    Should Value Investors Choose McKesson Corp (MCK) Stock?

    by Zacks Equity Research

    Let's see if McKesson Corp (MCK) stock is a good choice for value-oriented investors right now from multiple angles.

    Why Is McKesson (MCK) Up 8.9% Since Last Earnings Report?

    by Zacks Equity Research

    McKesson (MCK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

    Here's Why You Should Retain McKesson (MCK) Stock for Now

    by Zacks Equity Research

    McKesson (MCK) continues to benefit from multi-year strategic growth initiative and Distribution Solutions segment.

    Company News for Nov 4, 2020

    by Zacks Equity Research

    Companies In The News Are: W, HUM, MCK, CRUS

    McKesson (MCK) Q2 Earnings and Revenues Surpass Estimates

    by Zacks Equity Research

    McKesson's (MCK) fiscal second-quarter 2021 results benefit from strong segmental performance.

    McKesson (MCK) Q2 Earnings and Revenues Top Estimates

    by Zacks Equity Research

    McKesson (MCK) delivered earnings and revenue surprises of 24.03% and 2.50%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

    McKesson (MCK) to Post Q2 Earnings: What's in the Offing?

    by Zacks Equity Research

    McKesson's (MCK) fiscal second-quarter results are likely to reflect solid show by U.S. Pharmaceutical and Specialty Solutions segment.

    Trina Mukherjee headshot

    3 Dental Supplies Stocks Set to Shine on the Industry's Upturn

    by Trina Mukherjee

    Despite the challenges thrown by the COVID-19 pandemic, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical - Dental Supplies industry. CAH, WST and MCK are well positioned to gain from the prospects.

    MCK or WST: Which Is the Better Value Stock Right Now?

    by Zacks Equity Research

    MCK vs. WST: Which Stock Is the Better Value Option?

    Trina Mukherjee headshot

    Dental Market Picks Up Pace Amid COVID-19: 3 Stocks to Watch

    by Trina Mukherjee

    Let's keep a watch on potentially strong three stocks in the dental space that have shown promise during the pandemic.